Group One Trading’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-38,499
| Closed | -$8K | – | 5863 |
|
|
2018
Q1 | $8K | Buy |
38,499
+36,343
| +1,686% | +$33.5K | ﹤0.01% | 4406 |
|
|
2017
Q4 | $3K | Buy |
+2,156
| New | +$3.51K | ﹤0.01% | 4677 |
|
|
2017
Q1 | – | Sell |
-9,572
| Closed | -$37.8K | – | 5445 |
|
|
2016
Q4 | $17K | Buy |
9,572
+4,310
| +82% | +$10.1K | ﹤0.01% | 3779 |
|
|
2016
Q3 | $17K | Sell |
5,262
-129
| -2% | -$487 | ﹤0.01% | 3870 |
|
|
2016
Q2 | $23K | Buy |
5,391
+2,133
| +65% | +$9.64K | ﹤0.01% | 3746 |
|
|
2016
Q1 | $18K | Buy |
+3,258
| New | +$42.3K | ﹤0.01% | 3807 |
|
|
2015
Q4 | – | Sell |
-40,112
| Closed | -$956K | – | 5634 |
|
|
2015
Q3 | $846K | Buy |
40,112
+30,619
| +323% | +$1.05M | 0.01% | 1370 |
|
|
2015
Q2 | $470K | Buy |
+9,493
| New | +$568K | 0.01% | 1834 |
|
|
2014
Q4 | – | Sell |
-27,812
| Closed | -$1.4M | – | 5881 |
|
|
2014
Q3 | $1.19M | Sell |
27,812
-963
| -3% | -$51.7K | 0.02% | 983 |
|
|
2014
Q2 | $1.78M | Buy |
+28,775
| New | +$1.67M | 0.03% | 781 |
|
|
2014
Q1 | – | Sell |
-3,824
| Closed | -$259K | – | 6079 |
|
|
2013
Q4 | $215K | Sell |
3,824
-466
| -11% | -$26.2K | ﹤0.01% | 2365 |
|
|
2013
Q3 | $263K | Sell |
4,290
-3,250
| -43% | -$220K | 0.01% | 2138 |
|
|
2013
Q2 | $441K | Buy |
+7,540
| New | +$464K | 0.01% | 1455 |
|
Other funds holding OREX
Group One Trading's OREX Position: Q2 2018 in Review
Group One Trading sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 38,499 shares — an estimated $8K sold.
Group One Trading first reported a position in OREX in Q2 2013 and held it in 13 quarters. The position peaked at $1.78M in Q2 2014. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.
- Group One Trading reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
- Group One Trading sold 38,499 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $8K.
- Group One Trading first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 13 quarters.
- Group One Trading's Orexigen Therapeutics, Inc. position peaked at $1.78M in Q2 2014.
- 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.
Based on Group One Trading's 13F filing for Q2 2018, filed 14 Aug 2018.